Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Search in:

Advanced search

Expert Opinion on Drug Safety Volume 21, 2022 - Issue 1

Submit an article Journal homepage

Open access

3,184

Views

CrossRef citations to date

Altmetric

Review

The safety of current treatment options for advanced esophageal cancer after first-line chemotherapy

Go IkedaDepartment of Head and Neck, Esophageal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan

Shun YamamotoDepartment of Head and Neck, Esophageal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan

Ken KatoDepartment of Head and Neck, Esophageal Medical Oncology, National Cancer Center Hospital, Tokyo, JapanCorrespondence[email protected]

https://orcid.org/0000-0002-1733-5072

Pages 55-65 | Received 10 Feb 2021, Accepted 09 Jul 2021, Published online: 26 Jul 2021

Cite this article
https://doi.org/10.1080/14740338.2021.1955100
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (4)

Huiling Wang, Yufei Xu, Fengli Zuo, Junzhi Liu & Jiqiao Yang. (2022) Immune-based combination therapy for esophageal cancer. Frontiers in Immunology 13.
Crossref

Yogesh Vashist, Kornelia Aigner, Miriam Dam, Sabine Gailhofer & Karl R. Aigner. (2022) Regional Chemotherapy Is a Valuable Second-Line Approach in Metastatic Esophageal Cancer after Failure to First-Line Palliative Treatment. Current Oncology 29:7, pages 4868-4878.
Crossref

Yi Yang, Xiangliang Liu, Wei Song, Jin Lu, Na Yin, Xiaojun Ye & Xiao Chen. (2022) Case Report: First-Line Immunotherapy for Esophageal Squamous Carcinoma Combined With Hypopharyngeal Squamous Carcinoma Yields Sustained Survival Benefit. Frontiers in Immunology 13.
Crossref

Onyisi Christiana Didamson & Heidi Abrahamse. (2021) Targeted Photodynamic Diagnosis and Therapy for Esophageal Cancer: Potential Role of Functionalized Nanomedicine. Pharmaceutics 13:11, pages 1943.
Crossref

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references